Clinical Trials Logo

Clinical Trial Summary

A randomized, double-blind, placebo-controlled single center investigation of furosemide's effect on postpartum blood pressure control in pregnancies affected by hypertensive disorders of pregnancy


Clinical Trial Description

Hypertensive disorders of pregnancy are recognized causes of significant maternal/fetal morbidity and mortality, accounting for approximately 18% of maternal deaths worldwide. While significant research has been done on the evaluation and management of hypertension during pregnancy, studies of postpartum hypertension (PPHTN) are usually limited by their retrospective design and focus on inpatients in the immediate postpartum period (2-6 days), or patients who were readmitted due to complications related to hypertension. Few studies have investigated the incidence and proper management of hypertension in the postpartum period. Furthermore, in the United Kingdom, a review of maternal deaths determined that 10% were related to hypertensive disorders in pregnancy (HDP) in the postpartum period. Postpartum hypertension is also the cause of approximately 27% of readmissions to the hospital. These studies clearly show that PPHTN is associated with significant morbidity and that it is important to develop interventions that can reduce its effects.

In patients with HDP, postpartum blood pressure has been shown to decrease in the first 48 hours postpartum only to then increase in days 3-6 postpartum. This phenomenon is thought to be secondary to large fluid shifts, both secondary from fluid retention during the pregnant state as well as from fluids given intrapartum. Furthermore, large volumes of sodium are also mobilized into the intravascular compartment at this time. Given the latter, furosemide, a loop diuretic that mobilizes sodium and fluid excretion has been posed as a method to prevent severe range blood pressures and their associated maternal morbidity in the postpartum period. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03556761
Study type Interventional
Source University of Pennsylvania
Contact
Status Completed
Phase Phase 2
Start date June 20, 2018
Completion date February 5, 2020

See also
  Status Clinical Trial Phase
Completed NCT03613714 - Innovation in Postpartum Care for Women With Hypertensive Disorders of Pregnancy N/A
Completed NCT02338687 - Low Dose Calcium to Prevent Preeclampsia Phase 4
Completed NCT04752475 - Lasix for the Prevention of De Novo Postpartum Hypertension Phase 3
Completed NCT03334149 - Blood Pressure Monitoring in High Risk Pregnancy to Improve the Detection and Monitoring of Hypertension N/A
Recruiting NCT03298802 - Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide Phase 3
Completed NCT03076619 - A Clinical Study of Fundus Findings in Toxaemia of Pregnancy N/A
Recruiting NCT05473767 - Expanding the Family Check-Up in Early Childhood to Promote Cardiovascular Health of Mothers and Young Children N/A
Completed NCT03356106 - Screening and Treatment of Obstructive Sleep Apnea in High-risk Pregnancy N/A
Recruiting NCT05849103 - Comprehensive Postpartum Management for Women With Hypertensive Disorders of Pregnancy N/A
Recruiting NCT03200743 - Catestatin and Hypertension in Pregnancy N/A
Terminated NCT04343235 - Postpartum Management of Gestational Hypertensive Disorders Using Furosemide Phase 4
Completed NCT01508208 - Comparison of Urine Protein/Creatinine Ratio With 24-hour Urine Protein Excretion in Woman With Hypertensive Disorders N/A
Active, not recruiting NCT04580927 - Breastfeeding and Postpartum Cardiovascular Health N/A
Recruiting NCT03858595 - Optimizing Gestational Weight Gain, Birth Weight and Other Perinatal Outcomes Among Pregnant Women at Risk of Hypertension in Pregnancy N/A
Recruiting NCT05655936 - Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial N/A
Completed NCT02523781 - Evaluation of an Information Pamphlet for Postpartum Women That Had a Hypertensive Pregnancy N/A
Completed NCT01736826 - Free DNA and Nucleosome Concentrations in Pathological Pregnancies
Completed NCT00949260 - Hemodynamic Assessment of Healthy and Hypertensive Pregnant Women by Non-Invasive Bio-Reactance N/A
Active, not recruiting NCT04012151 - Arm and Finger Measurement for Blood Pressure Surveillance
Completed NCT04615624 - Furosemide vs. Placebo for Severe Antepartum Hypertension Phase 3